These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 25672406)

  • 1. Clinical outcomes of linezolid treatment for extensively drug-resistant tuberculosis in Beijing, China: a hospital-based retrospective study.
    Liu Y; Bao P; Wang D; Li Y; Tang L; Zhou Y; Zhao W
    Jpn J Infect Dis; 2015; 68(3):244-7. PubMed ID: 25672406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linezolid for patients with multidrug-resistant tuberculosis/extensively drug-resistant tuberculosis in China.
    Zhang P; Tan J; Lin Y; Zhang H; Deng G; Chen X
    Drug Discov Ther; 2022 May; 16(2):96-98. PubMed ID: 35444071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and treatment outcome of extensively drug-resistant tuberculosis plus additional drug resistance from the National Clinical Center for Tuberculosis in China: A five-year review.
    Pang Y; Lu J; Huo F; Ma Y; Zhao L; Li Y; Liang Q; Chu N; Gao M; Huang H
    J Infect; 2017 Nov; 75(5):433-440. PubMed ID: 28804028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of MDR/XDR-TB patients treated with linezolid: experience in Thailand.
    Roongruangpitayakul C; Chuchottaworn C
    J Med Assoc Thai; 2013 Oct; 96(10):1273-82. PubMed ID: 24350407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.
    Koh WJ; Kwon OJ; Gwak H; Chung JW; Cho SN; Kim WS; Shim TS
    J Antimicrob Chemother; 2009 Aug; 64(2):388-91. PubMed ID: 19468028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linezolid in the treatment of MDR-TB: a retrospective clinical study.
    Xu HB; Jiang RH; Li L; Xiao HP
    Int J Tuberc Lung Dis; 2012; 16(3):358-63. PubMed ID: 22640450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy, safety and tolerability of linezolid for the treatment of XDR-TB: a study in China.
    Tang S; Yao L; Hao X; Zhang X; Liu G; Liu X; Wu M; Zen L; Sun H; Liu Y; Gu J; Lin F; Wang X; Zhang Z
    Eur Respir J; 2015 Jan; 45(1):161-70. PubMed ID: 25234807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness and safety of imipenem/clavulanate and linezolid to treat multidrug and extensively drug-resistant tuberculosis at a referral hospital in Brazil.
    Arbex MA; Bonini EH; Kawakame Pirolla G; D'Ambrosio L; Centis R; Migliori GB
    Rev Port Pneumol (2006); 2016; 22(6):337-341. PubMed ID: 27481315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linezolid: an effective, safe and cheap drug for patients failing multidrug-resistant tuberculosis treatment in India.
    Singla R; Caminero JA; Jaiswal A; Singla N; Gupta S; Bali RK; Behera D
    Eur Respir J; 2012 Apr; 39(4):956-62. PubMed ID: 21965225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment outcomes of pre- and extensively drug-resistant tuberculosis in Johannesburg, South Africa.
    Nkurunziza J; Karstaedt AS; Louw R; Padanilam X
    Int J Tuberc Lung Dis; 2018 Dec; 22(12):1469-1474. PubMed ID: 30606319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of meropenem-clavulanate added to linezolid-containing regimens in the treatment of MDR-/XDR-TB.
    De Lorenzo S; Alffenaar JW; Sotgiu G; Centis R; D'Ambrosio L; Tiberi S; Bolhuis MS; van Altena R; Viggiani P; Piana A; Spanevello A; Migliori GB
    Eur Respir J; 2013 Jun; 41(6):1386-92. PubMed ID: 22997218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linezolid in the treatment of multidrug-resistant tuberculosis.
    Schecter GF; Scott C; True L; Raftery A; Flood J; Mase S
    Clin Infect Dis; 2010 Jan; 50(1):49-55. PubMed ID: 19947856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daily 300 mg dose of linezolid for multidrug-resistant and extensively drug-resistant tuberculosis: updated analysis of 51 patients.
    Koh WJ; Kang YR; Jeon K; Kwon OJ; Lyu J; Kim WS; Shim TS
    J Antimicrob Chemother; 2012 Jun; 67(6):1503-7. PubMed ID: 22403262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linezolid-containing regimens for the treatment of drug-resistant tuberculosis in South African children.
    Rose PC; Hallbauer UM; Seddon JA; Hesseling AC; Schaaf HS
    Int J Tuberc Lung Dis; 2012 Dec; 16(12):1588-93. PubMed ID: 23032215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidrug- and extensively drug-resistant tuberculosis, Germany.
    Eker B; Ortmann J; Migliori GB; Sotgiu G; Muetterlein R; Centis R; Hoffmann H; Kirsten D; Schaberg T; Ruesch-Gerdes S; Lange C;
    Emerg Infect Dis; 2008 Nov; 14(11):1700-6. PubMed ID: 18976552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linezolid use for treatment of multidrug-resistant and extensively drug-resistant tuberculosis, New York City, 2000-06.
    Anger HA; Dworkin F; Sharma S; Munsiff SS; Nilsen DM; Ahuja SD
    J Antimicrob Chemother; 2010 Apr; 65(4):775-83. PubMed ID: 20150181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of extensively drug-resistant tuberculosis among patients with multidrug-resistant tuberculosis: a retrospective hospital-based study.
    Sharma SK; George N; Kadhiravan T; Saha PK; Mishra HK; Hanif M
    Indian J Med Res; 2009 Oct; 130(4):392-5. PubMed ID: 19942741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of pulmonary MDR-TB: impacts of fluoroquinolone resistance and linezolid treatment.
    Jeong BH; Jeon K; Park HY; Kwon OJ; Lee KS; Kim HK; Choi YS; Kim J; Huh HJ; Lee NY; Koh WJ
    J Antimicrob Chemother; 2015 Nov; 70(11):3127-33. PubMed ID: 26203184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful alternative treatment of extensively drug-resistant tuberculosis in Argentina with a combination of linezolid, moxifloxacin and thioridazine.
    Abbate E; Vescovo M; Natiello M; Cufré M; García A; Gonzalez Montaner P; Ambroggi M; Ritacco V; van Soolingen D
    J Antimicrob Chemother; 2012 Feb; 67(2):473-7. PubMed ID: 22134348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.